Abstract Protein–protein interactions are critical for regulating the activity of translation initiation factors and multitude of other cellular process, and form the largest block of untapped albeit most challenging targets for drug development. 4EGI-1,(E/Z)-2-(2-(4-(3, 4- dichlorophenyl) thiazol-2-yl) hydrazono)-3-(2-nitrophenyl) propanoic acid, is a hit compound discovered in a screening campaign of small molecule libraries as an inhibitor of ...